Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NK1 Receptor Antagonist. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113582982B reveals a novel chiral resolution and coupling route for Aprepitant, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.